How to code NSTEMI vs type 2 MI: ICD-10-CM guide

Table of Contents

1. What are NSTEMI and type 2 MI?
   1. Type 1 NSTEMI (I21.4)
   2. Type 2 MI (I21.A1)
2. What criteria distinguish type 1 NSTEMI from type 2 MI?
   1. Etiology and pathophysiology
   2. Diagnostic criteria per the Fourth Universal Definition
   3. Clinical context and underlying causes
3. How do NSTEMI and type 2 MI compare side by side?
   1. Etiology and mechanism
   2. Coding and sequencing rules
   3. Quality metric implications
4. What should you verify before you code?
   1. Confirming MI type
   2. Verifying the underlying cause
   3. When to query the provider
5. How does MI coding affect reimbursement and quality metrics?
   1. MS-DRG and reimbursement impact
   2. Quality metrics and public reporting
   3. The 28-day temporal parameter
6. Which code fits which clinical scenario?
   1. Type 1 NSTEMI worked examples
   2. Type 2 MI worked examples
   3. Edge cases and mixed presentations
7. What coding mistakes should you avoid?
   1. Misusing I24.89 for demand ischemia
   2. Coding type 2 MI as NSTEMI
   3. Failing to sequence the underlying cause
8. Frequently asked questions
   1. If a provider documents "type 2 NSTEMI," which ICD-10-CM code do I assign?
   2. Can I use I24.89 for demand ischemia?
   3. What is the 28-day rule for subsequent MIs?
   4. Is coronary artery disease required for a type 2 MI diagnosis?
   5. What documentation supports a type 2 MI code?
   6. How does type 2 MI affect MS-DRG assignment?
9. Takeaways
10. Ready to code with confidence?

---

Type 1 and Type 2 MIs are both included in acute MI MS-DRGs, but only Type 1 MIs are included in the CMS 30-day AMI readmission and mortality cohort. Code I21.A1 for a Type 2 MI driven by an oxygen supply-demand mismatch, with the underlying cause coded first. The distinction rests on whether acute atherothrombosis is present. This guide walks inpatient coders and CDI specialists through the full decision path, from Fourth Universal Definition clinical criteria to ICD-10-CM code assignment, underlying-cause sequencing, and provider query.

What are NSTEMI and type 2 MI?

Knowing which type the documentation describes determines the code, the sequencing, and whether the case enters quality metric cohorts.

Type 1 NSTEMI (I21.4)

A non-ST elevation myocardial infarction is a Type 1 MI subtype caused by atherothrombotic coronary artery disease, typically precipitated by atherosclerotic plaque rupture or erosion. It requires troponin elevation above the 99th percentile. At least one of the following must also be present: ischemic symptoms, new ischemic ECG changes, pathological Q waves, imaging evidence of new wall motion abnormality, or angiographic identification of a coronary thrombus. Code I21.4 is sequenced as the principal diagnosis when the MI occasioned the admission.

Type 2 MI (I21.A1)

A Type 2 MI results from an imbalance between myocardial oxygen supply and demand unrelated to acute coronary atherothrombosis. Common triggers include anemia, sepsis, arrhythmia, shock, respiratory failure, and severe hypertension. The I21.A1 code was introduced to ICD-10-CM effective October 1, 2017 (FY2018).

It separated Type 2 MI from Type 1 NSTEMI, which had previously been lumped under other acute ischemic heart disease codes. The underlying cause is coded first, if applicable, followed by I21.A1 as a secondary diagnosis.

What criteria distinguish type 1 NSTEMI from type 2 MI?

The Fourth Universal Definition of MI (2018) defines five MI types based on their underlying mechanism, with Type 1 being atherothrombotic and Type 2 being supply-demand mismatch. The distinction rests on the presence or absence of acute plaque disruption. Troponin elevation alone cannot distinguish the two types because high-sensitivity assays detect myocardial injury but not its underlying pathophysiology, and troponin distributions overlap between the two types.

Etiology and pathophysiology

• Type 1 NSTEMI originates from atherosclerotic plaque rupture or erosion that triggers coronary thrombosis and myocyte necrosis
• Type 2 MI arises from an oxygen supply-demand mismatch without acute atherothrombosis
• The mechanism, not the troponin level, determines the type

Diagnostic criteria per the Fourth Universal Definition

• Both types require a rise and/or fall of cardiac troponin above the 99th percentile.
• Type 2 requires the same troponin criteria plus evidence of supply-demand mismatch unrelated to atherothrombosis, with at least one of the same ischemic evidence features

Clinical context and underlying causes

• Reduced perfusion: fixed coronary atherosclerosis without plaque rupture, coronary spasm, microvascular dysfunction (coded I21.B, not I21.A1, per Guideline I.C.9.e.6), coronary embolism, coronary dissection, severe bradyarrhythmia, respiratory failure with hypoxemia, severe anemia, hypotension or shock
• Increased demand: sustained tachyarrhythmia, severe hypertension with or without left ventricular hypertrophy
• The presence of an identifiable underlying cause is the deciding factor for Type 2 MI; its absence points toward Type 1
• When the documentation specifies plaque rupture, erosion, or thrombus on angiography, assign Type 1; when an underlying condition explains the troponin elevation, assign Type 2

How do NSTEMI and type 2 MI compare side by side?

The comparison table maps each criterion to the correct ICD-10-CM code, sequencing rule, and quality metric implication. The FY2025 ICD-10-CM tabular revision changed the I21.A1 instructional note from "Code first the underlying cause" to "Code first, if applicable, the underlying cause." This change acknowledges that the underlying cause may not always be identifiable.

Etiology and mechanism

The table rows for etiology and pathophysiology capture the core distinction: plaque disruption drives Type 1, while an underlying condition drives Type 2. Angiography showing a thrombus confirms Type 1; clean arteries or non-thrombotic lesions support Type 2.

Coding and sequencing rules

I21.4 is the principal diagnosis when the MI occasioned the admission. The FY2025 tabular revision changed the I21.A1 note to "Code first, if applicable, the underlying cause," allowing I21.A1 to be principal when no cause is identifiable.

Quality metric implications

Type 1 MIs (I21.0 through I21.4) are included in acute MI MS-DRGs and the CMS 30-day AMI readmission and mortality cohort. Type 2 MIs (I21.A1) also group to the AMI MS-DRGs as principal diagnosis, and as a secondary diagnosis may qualify as a CC or MCC affecting DRG assignment.

What should you verify before you code?

For Type 2, confirm the underlying cause is named. Also check whether the encounter is initial or subsequent within the 28-day window. Each row below identifies a question to ask, the answer to look for, and the red flag that should trigger a provider query.

Confirming MI type

Check whether the provider explicitly documents "Type 1 MI" or "Type 2 MI" with the etiology. The term "NSTEMI" alone codes to I21.4, the Type 1 code, so query if the clinical picture points to Type 2; if the documentation says "type 2 NSTEMI," Guideline I.C.9.e.5 directs you to assign only I21.A1.

Verifying the underlying cause

For Type 2 MI, confirm that a named underlying condition is documented as the cause. If no cause is documented, query the provider before final assignment.

When to query the provider

Query when documentation is ambiguous about MI type or lacks a named underlying cause for Type 2 MI. Compliant, clinically appropriate queries help physicians respond quickly, reducing delays in code assignment.

How does MI coding affect reimbursement and quality metrics?

Coding a Type 2 MI as I21.4 reports it as a Type 1 AMI in quality data, which inflates quality metric denominators and exposes the hospital to penalty risk.

MS-DRG and reimbursement impact

Type 2 MIs (I21.A1) group to the AMI MS-DRGs (280 to 285) when principal, and as a secondary diagnosis may qualify as a complication or comorbidity (CC or MCC) that affects DRG assignment and payment. Accurate sequencing of the underlying cause drives the DRG.

Quality metrics and public reporting

CMS uses primary discharge ICD-10 codes for AMI to define inclusion in value-based payment programs. A national study of over 250,000 patients found Type 2 MI patients had a lower adjusted risk of in-hospital death and of 30-day MI readmission, and no difference in 30-day all-cause readmission, per JACC.

The 28-day temporal parameter

Codes from category I21 apply when the MI is acute or within 4 weeks (28 days) of onset. After 28 days, if the patient is still receiving care for the MI, assign the appropriate aftercare code instead of I21. For old or healed MI, use I25.2.

For a subsequent Type 1 MI within 28 days, use category I22 with an I21 code. For a subsequent Type 2 MI, assign only I21.A1 again, not I22, per the 28-day rule.

Which code fits which clinical scenario?

Match the clinical presentation to the correct ICD-10-CM code and sequencing pattern using these worked examples.

Type 1 NSTEMI worked examples

• Choose I21.4 if: 65-year-old presents with chest pain, troponin 5x upper limit, ischemic ECG changes, no ST elevation, angiography shows plaque erosion. Assign I21.4 as principal diagnosis.
• Choose I21.4 if: 58-year-old with acute chest pain, troponin rise and fall, new T-wave inversions, coronary angiography shows thrombus in LAD. Assign I21.4 as principal diagnosis.

Type 2 MI worked examples

• Choose I21.A1 if: 72-year-old with septic shock, new troponin elevation, no plaque rupture on angiography. Assign A41.9 (sepsis) as principal, with R65.21 (septic shock) and I21.A1 as secondary.
• Choose I21.A1 if: 58-year-old with rapid atrial fibrillation and troponin rise, no coronary thrombus. Assign I48.91 (unspecified atrial fibrillation) as principal, I21.A1 as secondary.
• Choose I21.A1 if: 80-year-old with severe anemia (Hgb 6.2) and troponin elevation, no plaque rupture. Assign D64.9 (anemia) as principal, I21.A1 as secondary.

Edge cases and mixed presentations

• If documentation says "NSTEMI" but the clinical picture includes sepsis, shock, or severe anemia with no angiographic thrombus, query whether this is Type 2 MI.
• If a subsequent MI within 28 days is Type 2, assign I21.A1 again, not I22.
• If the MI occurred more than 28 days ago and care for it continues, assign the appropriate aftercare code, not I21.

What coding mistakes should you avoid?

The most frequent NSTEMI and Type 2 MI coding errors stem from using the wrong code, ignoring sequencing rules, or accepting ambiguous documentation without querying. Each error below affects DRG assignment, quality metrics, or both.

Misusing I24.89 for demand ischemia

• Do not assign I24.89 for the demand ischemia when a Type 2 MI is documented. The ICD-10-CM Tabular List has an Excludes1 note at I24.8 directing coders to I21.A1 for MI due to demand ischemia.
• I24.89 is reserved for acute ischemic heart disease that does not meet MI criteria, including demand ischemia without infarction.

Coding type 2 MI as NSTEMI

• If documentation says "type 2 NSTEMI," assign I21.A1 only. Per Guideline I.C.9.e.5, the MI type takes precedence over the NSTEMI descriptor.
• No query is needed for "type 2 NSTEMI"; the guideline already settles it. Type 1 and Type 2 MIs are both included in acute MI MS-DRGs, but only Type 1 MIs are included in the CMS 30-day AMI readmission and mortality cohort.

Failing to sequence the underlying cause

• Failing to sequence correctly affects DRG assignment and quality metric reporting.
• Using category I22 for a subsequent Type 2 MI is incorrect; I22 applies only to subsequent Type 1 or unspecified MIs. For subsequent Type 2, assign I21.A1 again.
• Not querying when documentation is ambiguous about MI type or lacks a named underlying cause for Type 2 MI leaves errors uncorrected before submission.

Frequently asked questions

If a provider documents "type 2 NSTEMI," which ICD-10-CM code do I assign?

Assign I21.A1 only. Per ICD-10-CM Official Guideline I.C.9.e.5, if a Type 2 AMI is described as NSTEMI, only I21.A1 is assigned. The MI type takes precedence over the NSTEMI descriptor, so no query is needed.

Can I use I24.89 for demand ischemia?

Not when the demand ischemia caused a Type 2 MI. Per the ICD-10-CM Official Guidelines, use I21.A1 for Type 2 MI and code the underlying cause first, if applicable.

I24.89 is reserved for other acute ischemic heart disease that does not meet MI criteria, including demand ischemia without infarction. The Excludes1 note at I24.8 directs MI due to demand ischemia to I21.A1.

What is the 28-day rule for subsequent MIs?

For encounters within four weeks (28 days) of an MI, codes from category I21 may continue to be reported. After four weeks, if care for the MI continues, assign the appropriate aftercare code instead. For a subsequent Type 1 MI within four weeks, use category I22 with an I21 code. For subsequent Type 2 MI, assign only I21.A1, not I22.

Is coronary artery disease required for a type 2 MI diagnosis?

No. Coronary artery disease may be present but is not required. Type 2 MI is defined by an oxygen supply-demand mismatch from an underlying condition. The presence or absence of CAD does not determine whether the MI is Type 1 or Type 2.

What documentation supports a type 2 MI code?

Documentation should include the MI type (Type 2), the underlying cause (anemia, sepsis, arrhythmia, shock, respiratory failure), and evidence of supply-demand mismatch. The underlying cause should be documented as the primary diagnosis, with Type 2 MI as a secondary diagnosis.

How does type 2 MI affect MS-DRG assignment?

Type 1 and Type 2 MIs are both included in acute MI MS-DRGs, but only Type 1 MIs are included in the CMS 30-day AMI readmission and mortality cohort.

Takeaways

• Troponin elevation alone cannot distinguish Type 1 from Type 2; the clinical context and presence of an underlying trigger determine the type.
• Never use I24.89 for demand ischemia that resulted in an MI; the Excludes1 note at I24.8 directs you to I21.A1.
• Query the provider when documentation is ambiguous about the MI type or lacks a named underlying cause for Type 2 MI; for "type 2 NSTEMI," assign I21.A1 without a query.

Ready to code with confidence?

Use CLAIRE's AI medical coding assistant to interpret clinical documentation, confirm the correct ICD-10-CM code for NSTEMI or Type 2 MI, and generate compliant CDI queries when documentation is ambiguous. Built by coders for coders, it provides instant, expert-level coding guidance with explanations of clinical reasoning, so you can assign the right code the first time.